Is TP53 Mutated AML the Same Disease as TP53 Mutated MDS?

被引：0
|
作者：
Valk, Peter J. M. [1 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
AML; MDS-EB; TP53; mutation; outcome; ALLELE FREQUENCY; MUTATIONS; OUTCOMES;
D O I：
10.1016/S2152-2650(22)00640-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：S3 / S5
页数：3
相关论文
共 50 条
  • [1] Patterns of mutations in TP53 mutated AML
    Welch, John S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (04) : 379 - 383
  • [2] TP53 mutated acute myeloid leukemia
    Sill, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 257 - 257
  • [3] Current status and new treatment approaches in TP53 mutated AML
    Hunter, Anthony M.
    Sallman, David A.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (02) : 134 - 144
  • [4] Somatic Mutations in TP53 Identified in T-Cells of Patients with TP53-mutated AML
    Issa, Ghayas C.
    Bidikian, Aram
    Ayoub, Edward
    Wang, Feng
    Mohanty, Vakul
    Leighton, Jake
    Wu, Xiaogang
    Patsilevas, Tallie
    Alaniz, Zoe
    Zarka, Jabra
    Kanagal-Shamanna, Rashmi
    Daver, Naval
    Futreal, Andy
    Konopleva, Marina
    Navin, Nicholas
    Zhang, Jianhua
    Chen, Ken
    Andreeff, Michael
    BLOOD, 2022, 140 : 6267 - 6269
  • [5] Prevalence of mutated TP53 on cDNA (but not on DNA template) in pleomorphic xanthoastrocytoma with positive TP53 immunohistochemistry
    Zakrzewska, Magdalena
    Szybka, Malgorzata
    Biernat, Wojciech
    Papierz, Tomasz
    Rieske, Piotr
    Liberski, Pawel P.
    Zakrzewski, Krzysztof
    CANCER GENETICS AND CYTOGENETICS, 2009, 193 (02) : 93 - 97
  • [6] TP53 Allelic Status in TP53 Mutated Therapy-Related Myeloid Neoplasms is Inconsequential
    Zak, Taylor
    Sukhanova, Madina
    Gao, Juehua
    Behdad, Amir
    Chen, Yi-Hua
    Chen, Qing
    Tariq, Hamza
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1520 - S1522
  • [7] INTRODUCING WILDTYPE TP53 IN TP53 MUTATED MYELOID LEUKEMIAS IMPROVES SENSITIVITY TO CHEMOTHERAPEUTIC DRUGS
    Maity, Arnab
    Illangeswaran, Raveen
    Rajamani, Bharathi
    Choudhury, Anurag
    Velayudhan, Shaji
    Kulkarni, Uday
    Balasubramanian, Poonkuzhaki
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [8] Mutated and non-mutated TP53 as targets in the treatment of leukaemia
    Nahi, H.
    Selivanova, G.
    Lehmann, S.
    Mollgard, L.
    Bengtzen, S.
    Concha, H.
    Svensson, A.
    Wiman, K. G.
    Merup, M.
    Paul, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (04) : 445 - 453
  • [9] TP53 or Not TP53: That Is the Question
    Green, Steven D.
    Zeidner, Joshua F.
    CLINICAL CANCER RESEARCH, 2022, 28 (24) : 5235 - 5237
  • [10] Smoking and Its Prognostic Effect on Survival in Patients with TP53 Mutated MDS
    Reilly, Sean Patrick
    Bi, Xia
    French, Zachary
    Wilde, Lindsay
    Palmisiano, Neil
    BLOOD, 2022, 140 : 12339 - 12340
12345